Literature DB >> 16076768

Induction of rat hepatic cytochrome P-450 by ketamine and its toxicological implications.

Wei-Hung Chan1, Wei-Zen Sun, Tzuu-Huei Ueng.   

Abstract

Ketamine is a common intravenous anesthetic and a frequent drug of abuse, alone or in combination with cocaine. However, the pharmacokinetic effects of ketamine have not been fully investigated. This study determined the effects of ketamine on cytochrome P-450 (P-450)-dependent catalytic activities, protein levels, and hepatotoxicity using male Wistar rats treated with 10, 20, 40, or 80 mg/kg ketamine intraperitoneally twice daily for 4 d. Treatment with ketamine produced a dose-dependent increase of pentoxyresorufin O-dealkylation activity of liver microsomes. Treatment with 80 mg/kg ketamine resulted in 14-, 3-, and 2-fold rise in O-dealkylation of pentoxyresorufin, ethoxyresorufin, and methoxyresorufin of rat liver microsomes, respectively. The treatment produced 31% and 86% increases in 7-ethoxycoumarin O-deethylation and erythromycin N-demethylation, respectively. In addition, aniline hydroxylation activity was elevated by 62%. Protein blot analysis of liver microsomal proteins revealed that 80 mg/kg ketamine induced P-450 1A, 2B, 2E1, and 3A proteins by 2-, 13-, 2-, and 2-fold, respectively. In reversibility study, ketamine-induced pentoxyresorufin O-dealkylation, 7-ethoxycoumarin O-deethylation, erythromycin N-demethylation, and methoxyresorufin O-demethylation activities of liver microsomes prepared from rats 4 d after ketamine treatment were 75%, 48%, 29%, and 38% lower than the respective activities of liver microsomes prepared from rats 1 d after treatment. Protein blot analysis showed that ketamine-induced P-450 2B1/2 proteins also decreased in a time-dependent manner in 4 d. In hepatotoxicity study, treatment of rats with 1 ml/kg CCl4 produced a 7-fold increase in serum alanine aminotransferase activity level and a 17-fold rise in rats pretreated with 80 mg/kg ketamine for 4 d. Treatment of ICR mice with 120 mg/kg cocaine produced a 17% mortality, whereas the same dose of cocaine produced a 50% mortality in mice pretreated with ketamine. Treatment of mice with 100 mg/kg cocaine produced a 76-fold increase in serum alanine aminotransferase activity level and a 260-fold rise in mice pretreated with 80 mg/kg ketamine for 4 d. The present study shows that ketamine induces the expression of multiple forms of P-450 in rat liver microsomes and increases CCl4-induced liver toxicity and cocaine-mediated acute toxicity. Other potential pharmacological or toxicological events related to ketamine use need to be further explored.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076768     DOI: 10.1080/15287390590967522

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  7 in total

1.  Subchronic administration of (R,S)-ketamine induces ketamine ring hydroxylation in Wistar rats.

Authors:  R Moaddel; M Sanghvi; A Ramamoorthy; K Jozwiak; N Singh; C Green; K O'Loughlin; M Torjman; I W Wainer
Journal:  J Pharm Biomed Anal       Date:  2016-03-14       Impact factor: 3.935

2.  Stereoselective and regiospecific hydroxylation of ketamine and norketamine.

Authors:  Zeruesenay Desta; Ruin Moaddel; Evan T Ogburn; Cong Xu; Anuradha Ramamoorthy; Swarajya Lakshmi Vattem Venkata; Mitesh Sanghvi; Michael E Goldberg; Marc C Torjman; Irving W Wainer
Journal:  Xenobiotica       Date:  2012-05-21       Impact factor: 1.908

3.  Norketamine, the Main Metabolite of Ketamine, Induces Mitochondria-Dependent and ER Stress-Triggered Apoptotic Death in Urothelial Cells via a Ca2+-Regulated ERK1/2-Activating Pathway.

Authors:  Jhe-Wei Lin; Yi-Chun Lin; Jui-Ming Liu; Shing-Hwa Liu; Kai-Min Fang; Ren-Jun Hsu; Chun-Fa Huang; Kai-Yao Chang; Kuan-I Lee; Kai-Chih Chang; Chin-Chuan Su; Ya-Wen Chen
Journal:  Int J Mol Sci       Date:  2022-04-23       Impact factor: 6.208

4.  Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.

Authors:  Axel Becker; Gisela Grecksch; Gerald Zernig; Elisabeth Ladstaetter; Christoph Hiemke; Ulrich Schmitt
Journal:  Psychopharmacology (Berl)       Date:  2008-09-23       Impact factor: 4.530

5.  Obstructive nephropathy and kidney injury associated with ketamine abuse.

Authors:  Nicholas M Selby; John Anderson; Peter Bungay; Lindsay J Chesterton; Nitin V Kolhe
Journal:  NDT Plus       Date:  2008-05-21

6.  The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use.

Authors:  Sarbjeet S Kalsi; David M Wood; Paul I Dargan
Journal:  Emerg Health Threats J       Date:  2011-04-15

Review 7.  Metabolism and metabolomics of ketamine: a toxicological approach.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Forensic Sci Res       Date:  2017-02-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.